Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Medical Systems
Published in: Journal of Medical Systems 3/2019

01-03-2019 | Mobile & Wireless Health

Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists’ and Patients’ Perspectives

Authors: Eskinder Eshetu Ali, Sharlene Si Ling Chan, Huan Yu Poh, Yosua Amadeus Susanto, Thendral Suganya, Jo Lene Leow, Chee Khiang Pang, Lita Chew, Kevin Yi-Lwern Yap

Published in: Journal of Medical Systems | Issue 3/2019

Login to get access

Abstract

Smartphone apps can potentially help in enhancing oral anticancer medication (OAM) adherence. Patient adoption and efficacy of such apps depends on inclusion of user-centred and evidence-based features. The objective of this study was to identify important design considerations from the perspectives of patients taking OAMs, caregivers and oncology pharmacists. The study employed a qualitative study design. Data were collected using in-depth interviews with patients (n = 15), caregivers (n = 3) and pharmacists (n = 16). Interviews were audio-recorded, transcribed verbatim and inductive thematic analysis approach was used in data analysis. Monitoring medication-related problems, medication information, replacement of or integration with current systems and accessibility of app content on devices other than smartphones were the key themes identified in the analysis. Flexible input methods for monitored data, glanceability of monitored reports/information, near real-time adherence enhancing and symptom management interventions and customisable reminder options were design considerations identified under the monitoring medication-related problems theme. Participants suggested the provision of focused and easily understandable medication information with a potential for personalisation. Integration of app-based adherence systems with patients’ electronic medical records with added mechanisms for alerts in the dispensing system was also suggested as a key design requirement to improve quality of patient care and facilitate adoption by clinicians. Finally, smartphones were the most favoured platform with optional accessibility of app content on other devices. In conclusion, important design considerations were identified through a user-centred design approach. The findings will help developers and clinicians in the design of new app-based systems and evaluation of existing ones.
Appendix
Available only for authorised users
Literature
1.
Sabaté, E., Adherence to long-term therapies: Evidence for action. Switzerland: World Health Organization, 2003.
2.
Barillet, M., Prevost, V., Joly, F., and Clarisse, B., Oral antineoplastic agents: How do we care about adherence? Br. J. Clin. Pharmacol. 80(6):1289–1302, 2015.CrossRef
3.
Greer, J. A., Amoyal, N., Nisotel, L., Fishbein, J. N., MacDonald, J., Stagl, J., Lennes, I., Temel, J. S., Safren, S. A., and Pirl, W. F., A systematic review of adherence to oral antineoplastic therapies. Oncologist 21(3):354–376, 2016.CrossRef
4.
Huang, W. C., Chen, C. Y., Lin, S. J., and Chang, C. S., Medication adherence to oral anticancer drugs: Systematic review. Expert Rev. Anticancer Ther. 16(4):423–432, 2016.CrossRef
5.
Shafrin, J., Sullivan, J., Chou, J. W., Neely, M. N., Doan, J. F., and Maclean, J. R., The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma. Cancer Manag. Res. 9:731–739, 2017.CrossRef
6.
Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Lang, I., Colleoni, M., and Thurlimann, B., Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence. J. Clin. Oncol. 34(21):2452–2459, 2016.CrossRef
7.
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., and Garcia-Cardenas, V., Economic impact of medication nonadherence by disease groups: A systematic review. BMJ Open 8:e016982, 2018.PubMedPubMedCentral
8.
Latremouille-Viau, D., Guerin, A., Gagnon-Sanschagrin, P., Dea, K., Cohen, B. G., and Joseph, G. J., Health care resource utilization and costs in patients with chronic myeloid leukemia with better adherence to tyrosine kinase inhibitors and increased molecular monitoring frequency. J. Manag. Care Spec. Pharm. 23(2):214–224, 2017.PubMed
9.
Gandhi, S., Day, L., Paramsothy, T., Giotis, A., Ford, M., Boudreau, A., and Pasetka, M., Oral anticancer medication adherence, toxicity reporting, and counseling: A study comparing health care providers and patients. J. Oncol. Pract. 11(6):498–504, 2015.CrossRef
10.
Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., and Van Hecke, A., Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review. Cancer Treat. Rev. 39(6):610–621, 2013.CrossRef
11.
Foulon, V., Schoffski, P., and Wolter, P., Patient adherence to oral anticancer drugs: An emerging issue in modern oncology. Acta Clin. Belg. 66(2):85–96, 2011.PubMed
12.
13.
Hershman, D. L., Sticking to it: Improving outcomes by increasing adherence. J. Clin. Oncol. 34(21):2440–2442, 2016.CrossRef
14.
Neven, P., Markopoulos, C., Tanner, M., Marty, M., Kreienberg, R., Atkins, L., Franquet, A., Gnant, M., Neciosup, S., Tesarova, P., Barni, S., and Deschamp, V., The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: First-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (cariatide) study. Breast 23(4):393–399, 2014.CrossRef
15.
Gebbia, V., Bellavia, M., Banna, G. L., Russo, P., Ferrau, F., Tralongo, P., and Borsellino, N., Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer. Clin. Lung Cancer 14(4):390–398, 2013.CrossRef
16.
Mathes, T., Antoine, S.-L., Pieper, D., and Eikermann, M., Adherence enhancing interventions for oral anticancer agents: A systematic review. Cancer Treat. Rev. 40(1):102–108, 2014.CrossRef
17.
Sommers, R. M., Miller, K., and Berry, D. L., Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncol. Nurs. Forum 39(4):E373–E379, 2012.CrossRef
18.
Hadji, P., Blettner, M., Harbeck, N., Jackisch, C., Luck, H. J., Windemuth-Kieselbach, C., Zaun, S., and Kreienberg, R., The patient's anastrozole compliance to therapy (pact) program: A randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. Ann. Oncol. 24(6):1505–1512, 2013.CrossRef
19.
Kav, S., and Tokdemir, G., The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy. Asia Pac. J. Oncol. Nurs. 4(4):290, 2017.CrossRef
20.
Spoelstra, S. L., Given, C. W., Sikorskii, A., Coursaris, C. K., Majumder, A., DeKoekkoek, T., Schueller, M., and Given, B. A., Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: A randomized controlled trial. Telemed. J. E Health 22(6):497–506, 2016.CrossRef
21.
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., and Haynes, R.B., Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. (11):Cd000011, 2014.
22.
Car, J., Tan, W. S., Huang, Z., Sloot, P., and Franklin, B. D., Ehealth in the future of medications management: Personalisation, monitoring and adherence. BMC Med. 15(1):73, 2017.CrossRef
23.
24.
25.
26.
Haase, J., Farris, K. B., and Dorsch, M. P., Mobile applications to improve medication adherence. Telemed. J. E Health 23(2):75–79, 2017.CrossRef
27.
Spoelstra, S. L., and Sansoucie, H., Putting evidence into practice: Evidence-based interventions for oral agents for cancer. Clin. J. Oncol. Nurs. 19(3 Suppl):60–72, 2015.CrossRef
28.
Tricarico, C., Peters, R., Som, A., Javaherian, K., and Ross, W., Epxmedtracking: Feasibility evaluation of an sms-based medication adherence tracking system in community practice. JMIR Res. Protoc. 6(5):e87, 2017.CrossRef
29.
Marcum, Z. A., Sevick, M. A., and Handler, S. M., Medication nonadherence: A diagnosable and treatable medical condition. JAMA 309(20):2105–2106, 2013.CrossRef
30.
de Vries, S. T., Denig, P., Lasheras Ruiz, C., Houyez, F., Wong, L., Sutcliffe, A., PGM, M., and Consortium IMIW-RWPb, Interest in a mobile app for two-way risk communication: A survey study among european healthcare professionals and patients. Drug Saf., 2018. https://​doi.​org/​10.​1007/​s40264-018-0648-0.
31.
32.
Azevedo, R., Bernardes, M., Fonseca, J., and Lima, A., Smartphone application for rheumatoid arthritis self-management: Cross-sectional study revealed the usefulness, willingness to use and patients' needs. Rheumatol. Int. 35(10):1675–1685, 2015.CrossRef
33.
Israni, A., Dean, C., Kasel, B., Berndt, L., Wildebush, W., and Wang, C. J., Why do patients forget to take immunosuppression medications and miss appointments: Can a mobile phone app help? JMIR Publ. Health Surveill. 2(1):e15, 2016.CrossRef
34.
Kessel, K. A., Vogel, M. M., Schmidt-Graf, F., and Combs, S. E., Mobile apps in oncology: A survey on health care professionals' attitude toward telemedicine, mhealth, and oncological apps. J. Med. Internet Res. 18(11):e312, 2016.CrossRef
35.
Kessel KA, Vogel MME, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, von Eisenhart-Rothe R, Meyer B, Kiechle M, Keller U, Peschel C, Schmid RM, Combs SE (2017) Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth 5 (6):e81.
36.
Ali, E. E., Teo, A. K. S., Goh, S. X. L., Chew, L., and Yap, K. Y., MedAd-AppQ: A quality assessment tool for medication adherence apps on iOS and Android platforms. Res. Soc. Adm. Pharm. 14:1125–1133, 2018.
37.
Dayer, L. E., Shilling, R., Van Valkenburg, M., Martin, B. C., Gubbins, P. O., Hadden, K., and Heldenbrand, S., Assessing the medication adherence app marketplace from the health professional and consumer vantage points. JMIR Mhealth Uhealth 5(4):e45, 2017.CrossRef
38.
Santo, K., Richtering, S. S., Chalmers, J., Thiagalingam, A., Chow, C. K., and Redfern, J., Mobile phone apps to improve medication adherence: A systematic stepwise process to identify high-quality apps. JMIR Mhealth Uhealth 4(4):e132, 2016.CrossRef
39.
Ahmed, I., Ahmad, N. S., Ali, S., Ali, S., George, A., Saleem Danish, H., Uppal, E., Soo, J., Mobasheri, M. H., King, D., Cox, B., and Darzi, A., Medication adherence apps: Review and content analysis. JMIR Mhealth Uhealth 6(3):e62, 2018.CrossRef
40.
McCurdie, T., Taneva, S., Casselman, M., Yeung, M., McDaniel, C., Ho, W., and Cafazzo, J., Mhealth consumer apps: The case for user-centered design. Biomed. Instrum. Technol. 46(S2):49–56, 2012.CrossRef
41.
Bernhard, G., Mahler, C., Seidling, H. M., Stützle, M., Ose, D., Baudendistel, I., Wensing, M., and Szecsenyi, J., Developing a shared patient-centered, web-based medication platform for type 2 diabetes patients and their health care providers: Qualitative study on user requirements. J. Med. Internet Res. 20(3):e105, 2018.CrossRef
42.
Williamson, S. S., Gorman, P. N., and Jimison, H. B., A mobile/web app for long distance caregivers of older adults: Functional requirements and design implications from a user centered design process. AMIA Annu. Symp. Proc. 2014:1960–1969, 2014.
43.
Paolella, G. A., Boyd, A. D., Wirth, S. M., Cuellar, S., Venepalli, N. K., and Crawford, S. Y., Adherence to oral anticancer medications: Evolving interprofessional roles and pharmacist workforce considerations. Pharmacy (Basel, Switzerland) 6(1):23, 2018.
44.
Hsu, G. I.-H., Crawford, S. Y., Paolella, G., Cuellar, S., Wirth, S. M., Venepalli, N. K., Wang, E., Hughes, D., and Boyd, A. D., Design of customized mobile application for patient adherence to oral anticancer medications utilizing user-centered design. J. Biocommun. 41(1):5–14, 2017.CrossRef
45.
Fishbein, J. N., Nisotel, L. E., MacDonald, J. J., Amoyal Pensak, N., Jacobs, J. M., Flanagan, C., Jethwani, K., and Greer, J. A., Mobile application to promote adherence to oral chemotherapy and symptom management: A protocol for design and development. JMIR Res. Protoc. 6(4):e62, 2017.CrossRef
46.
Whiteley, L., Brown, L., Lally, M., Heck, N., and van den Berg, J. J., A mobile gaming intervention to increase adherence to antiretroviral treatment for youth living with hiv: Development guided by the information, motivation, and behavioral skills model. JMIR Mhealth Uhealth 6(4):e96, 2018.CrossRef
47.
48.
Fraccaro, P., Vigo, M., Balatsoukas, P., van der Veer, S. N., Hassan, L., Williams, R., Wood, G., Sinha, S., Buchan, I., and Peek, N., Presentation of laboratory test results in patient portals: Influence of interface design on risk interpretation and visual search behaviour. BMC Med. Inform. Decis. Mak. 18(1):11, 2018.CrossRef
49.
Ali, E. E., Cheung, K. L., Lee, C. P., Leow, J. L., Yap, K. Y., and Chew, L., Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore. Asia Pac. J. Oncol. Nurs. 4(4):283–289, 2017.CrossRef
50.
Braun, V., and Clarke, V., Using thematic analysis in psychology. Qual. Res. Psychol. 3(2):77–101, 2006.CrossRef
51.
52.
Mirkovic, J., Kaufman, D. R., and Ruland, C. M., Supporting cancer patients in illness management: Usability evaluation of a mobile app. JMIR Mhealth Uhealth 2(3):e33, 2014.CrossRef
53.
Darlow, S., and Wen, K.-Y., Development testing of mobile health interventions for cancer patient self-management: A review. Health Inform. J 22(3):633–650, 2016.CrossRef
54.
Whittaker, R., Merry, S., Dorey, E., and Maddison, R., A development and evaluation process for mhealth interventions: Examples from New Zealand. J. Health. Commun. 17(Suppl 1):11–21, 2012.CrossRef
55.
56.
Joyce, G., Lilley, M., Barker, T., and Jefferies, A., Mobile application usability: Heuristic evaluation and evaluation of heuristics. In: Advances in human factors, software, and systems engineering. Springer International Publishing, 77–86, 2016.
57.
Alpert, J. M., Morris, B. B., Thomson, M. D., Matin, K., and Brown, R. F., Implications of patient portal transparency in oncology: Qualitative interview study on the experiences of patients, oncologists, and medical informaticists. JMIR Cancer 4(1):e5, 2018.CrossRef
58.
Finitsis, D. J., Pellowski, J. A., and Johnson, B. T., Text message intervention designs to promote adherence to antiretroviral therapy (art): A meta-analysis of randomized controlled trials. PloS One 9(2):e88166, 2014.CrossRef
59.
Liu, X., Lewis, J. J., Zhang, H., Lu, W., Zhang, S., Zheng, G., Bai, L., Li, J., Li, X., Chen, H., Liu, M., Chen, R., Chi, J., Lu, J., Huan, S., Cheng, S., Wang, L., Jiang, S., Chin, D. P., and Fielding, K. L., Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: A cluster-randomised trial. PLoS Med. 12(9):e1001876, 2015.CrossRef
60.
61.
62.
Cheng, C., and Dunn, M., How well are health information websites displayed on mobile phones? Implications for the readability of health information. Health Promot. J. Austr. 28(1):15–20, 2017.CrossRef
Metadata
Title
Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists’ and Patients’ Perspectives
Authors
Eskinder Eshetu Ali
Sharlene Si Ling Chan
Huan Yu Poh
Yosua Amadeus Susanto
Thendral Suganya
Jo Lene Leow
Chee Khiang Pang
Lita Chew
Kevin Yi-Lwern Yap
Publication date
01-03-2019
Publisher
Springer US
Published in
Journal of Medical Systems / Issue 3/2019
Print ISSN: 0148-5598
Electronic ISSN: 1573-689X
DOI
https://doi.org/10.1007/s10916-019-1168-x

Other articles of this Issue 3/2019

Journal of Medical Systems 3/2019 Go to the issue

Image & Signal Processing

ECM-CSD: An Efficient Classification Model for Cancer Stage Diagnosis in CT Lung Images Using FCM and SVM Techniques

Systems-Level Quality Improvement

Machine Learning Can Improve Estimation of Surgical Case Duration: A Pilot Study

Systems-Level Quality Improvement

Tracking the Progress of Wireless Infusion Pump Drug Library Updates– A Data-Driven Analysis of Pump Update Delays

Image & Signal Processing

Possibility of Assessing the Gastrointestinal Tract as a Complex System

Transactional Processing Systems

Archetype Development Process: A Case Study of Support Interoperability among Electronic Health Record in the State of Minas Gerais, Brazil

Education & Training

Evaluation of Central Fatigue by the Critical Flicker Fusion Threshold in Cyclists